SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jul. 31, 2024	Jul. 24, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average basic common shares (in shares)	13,349,000	12,993,000	13,236,000	12,919,000
Effect of stock options (in shares)	0	0	0	0
Effect of dilutive share awards (in shares)	0	0	0	0
Weighted average diluted common shares (in shares)	13,349,000	12,993,000	13,236,000	12,919,000
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	200,000	0	200,000	0
Aggregate shares to be sold, maximum					$ 50.0
Common stock repurchases
Repurchased shares of common stock under stock repurchase program (in shares)			0	0
Remaining authorized repurchase amount	$ 96.7		$ 96.7
2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%		0.50%
2025 Convertible Notes | Convertible Debt
Additional disclosure
Stated interest rate	0.50%		0.50%			0.50%
Option
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	900,000	1,200,000	900,000	1,200,000
Restricted Stock Units (RSUs)
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	100,000	500,000	100,000	500,000
Convertible Debt
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	300,000	800,000	600,000	1,200,000